Cell Therapy Manufacturing

- Lonza Netherlands B.V. -

Lonza Netherlands has experience with manufacturing Clinical Trial Material in Phase I to Phase III clinical trials. Next to clinical trial manufacturing, Lonza Netherlands is also equipped to support and manufacture for your commercial cell therapy product for Europe.

CHALLENGES in the C ell Therapy Industry relate to high variability:

  • Incoming material is obtained from patients or cell material. Parameters will vary.
  • Raw materials used in the manufacturing are not always GMP compliant. Batch-to batch consistency needs to be tested on the right cell type.
  • Variance in patient treatment schedules requires real-time manufacturing
  • Project specific QC assays demand deep cell biological knowledge

Lonza Netherlands solely focuses on Cell Therapy Manufacturing and brings experience with autologous and allogeneic manufacturing for clinical programs for clients to bring SOLUTIONS in the design of the clinical program:

  • Assist in the design of training for and qualification of tissue collection sites
  • Ensure batch-to batch consistency by setting correct parameters for incoming cell material
  • Identify and deal with critical steps and materials in the full manufacturing supply chain in support of your clinical study
  • Have teams ready for real time manufacturing in line with the rate of  patient recruitment
  • Ensure succesful real-time batch release due to intense operator qualification training & environmental trending




GMP Certification CMF Geleen

The Geleen Cell Manufacturing Facility was first GMP certified in 2012 by the Dutch authorities (IGZ).

Fact sheet

GMP Certification CMF Maastricht

Our Maastricht Cell Manufacturing Facility was first GMP certified in 2006 and has been successfully inspected by the Dutch Authorities (IGZ) on a regular basis thereafter.

Fact sheet